EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Greek Case–Control Replication Study of IKZF1 rs4132601 and CDKN2A rs3731217 in Childhood Acute Lymphoblastic Leukemia

Ioannis Kyriakidis iD, Spyridoula D Katsarou iD, Maria I Zervou iD, Nikolaos Katzilakis iD, Maria Stratigaki iD, Iordanis Pelagiadis iD, Eftichia Stiakaki iD

Genes · 10.06.2026 · 17 (6) · 682

DOI: 10.3390/genes17060682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 10.06.2026. Verfasst von Ioannis Kyriakidis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology-Oncology and Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion and Laborat…. Hauptthemen laut MEDLINE: Ikaros Transcription Factor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Cyclin-Dependent Kinase Inhibitor p16, Polymorphism, Single Nucleotide. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Inherited variants in IKZF1 and CDKN2A/2B are among the most consistently reported germline susceptibility markers for childhood acute lymphoblastic leukemia (ALL). Nonetheless, effect sizes differ across ancestry groups, age ranges, and immunophenotypic subtypes, making well-characterized population-specific replication studies valuable for refining ancestry-specific evidence. This study examined two sentinel variants with historical relevance, IKZF1 rs4132601 and CDKN2A rs3731217, within a pediatric Greek cohort.

Methods

A case–control study with retrospective case ascertainment and control recruitment through routine pediatric visits was conducted, comprising 50 children and adolescents with ALL and 91 healthy controls from Crete, Greece. Constitutional DNA was isolated from peripheral blood samples collected during remission in cases, while controls provided peripheral blood for targeted germline genotyping. Genotyping was performed using PCR-restriction fragment length polymorphism analysis. We evaluated Hardy–Weinberg equilibrium and genotype and allele distributions and analyzed the data using logistic regression models.

Results

Control minor allele frequencies were broadly compatible with public European reference data. Neither IKZF1 rs4132601 nor CDKN2A rs3731217 showed a significant association with susceptibility to childhood ALL under either genotype-based or additive models. Results remained consistent after excluding T-cell ALL cases. Exploratory genotype-phenotype analyses did not reveal robust associations with clinical or molecular features.

Conclusions

In this first Greek pediatric assessment of IKZF1 rs4132601 and CDKN2A rs3731217, no significant association with ALL susceptibility was observed. Within the constraints of limited statistical power, these negative findings provide population-specific evidence, refine regional allele-frequency and effect-size estimates, highlight the limitations of relying on single historical sentinel single-nucleotide polymorphisms (SNPs), and support future ancestry-informed and polygenic approaches in southeastern European cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ikaros Transcription FactorPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclin-Dependent Kinase Inhibitor p16Polymorphism, Single NucleotideCyclin-Dependent Kinase Inhibitor p18HumansFemaleGreeceChildCase-Control StudiesMaleAdolescentGene FrequencyGenetic Predisposition to DiseaseChild, PreschoolGenotypeRetrospective Studies

Stichwörter der Autor:innen

CDKN2AGreek populationIKZF1acute lymphoblastic leukemiaadolescentchildgermline susceptibilitypolymorphismrs3731217rs4132601

Substanzen

Ikaros Transcription FactorIKZF1 protein, humanCyclin-Dependent Kinase Inhibitor p16CDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p18

Autor:innen und Institutionen

  • Department of Pediatric Hematology-Oncology and Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion and Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine…
  • MSc Program "Hematology-Oncology of Childhood and Adolescence", School of Medicine, University of Crete, 71003 Heraklion, Greece.
  • Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, University of Crete, 71003 Heraklion, Greece.

ORCID-Profile: Ioannis Kyriakidis, Spyridoula D Katsarou, Maria I Zervou, Nikolaos Katzilakis, Maria Stratigaki, Iordanis Pelagiadis, Eftichia Stiakaki

Zitieren

APA

Kyriakidis, I., Katsarou, S. D., Zervou, M. I., Katzilakis, N., Stratigaki, M., Pelagiadis, I., & Stiakaki, E. (2026). A Greek Case–Control Replication Study of IKZF1 rs4132601 and CDKN2A rs3731217 in Childhood Acute Lymphoblastic Leukemia. Genes, 17(6), 682. https://doi.org/10.3390/genes17060682

Vancouver

Kyriakidis I, Katsarou SD, Zervou MI, Katzilakis N, Stratigaki M, Pelagiadis I, et al. A Greek Case–Control Replication Study of IKZF1 rs4132601 and CDKN2A rs3731217 in Childhood Acute Lymphoblastic Leukemia. Genes. 2026;17(6):682. doi:10.3390/genes17060682

BibTeX
@article{Kyriakidis2026,
  author = {Kyriakidis, Ioannis and Katsarou, Spyridoula D and Zervou, Maria I and Katzilakis, Nikolaos and Stratigaki, Maria and Pelagiadis, Iordanis and Stiakaki, Eftichia},
  title = {A Greek Case–Control Replication Study of IKZF1 rs4132601 and CDKN2A rs3731217 in Childhood Acute Lymphoblastic Leukemia},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {682},
  doi = {10.3390/genes17060682}
}
Kostenlos starten →